Equities

Cosma SA

COS:WSE

Cosma SA

Actions
  • Price (PLN)0.45
  • Today's Change0.012 / 2.74%
  • Shares traded94.82k
  • 1 Year change+4.65%
  • Beta--
Data delayed at least 15 minutes, as of Oct 18 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vabun SA is a Poland-based company engaged in the personal products industry. The Company produces and sells cosmetics and fragrances for male and female. Vabun SA's products portfolio encompasses perfumes, such as Vabun Classic, Vabun Silver, Vabun Gold and Vabun Sport, as well as shower gels, soaps and other cosmetics for women.

  • Revenue in PLN (TTM)3.95m
  • Net income in PLN-47.03m
  • Incorporated2015
  • Employees31.00
  • Location
    Cosma SAUl. Woloska 22AKRAKOW 02-675PolandPOL
  • Phone+48 126540519
  • Fax+48 126540519
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
COS:WSE since
announced
Transaction
value
Undisclosed Pharmaceuticals DistributorAnnounced15 Dec 202315 Dec 2023Announced-8.16%--
Data delayed at least 15 minutes, as of Oct 18 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nyrada Inc9.04m-3.70m60.51m----4.51--6.69-0.0081-0.00810.02090.02770.6147-------25.13-53.28-29.75-62.52-----40.89-236.15----0.00--115.5546.4282.12------
Extrawell Pharmaceutical Holdings Ltd30.13m-83.07m60.92m159.00--0.1074--2.02-0.0682-0.06820.02470.46570.04335.9011.81371,685.50-11.831.01-12.321.0648.7050.54-273.5118.003.31-0.07530.09770.00-18.57-7.91-226.06---3.20--
Cilo Cybin Holdings Ltd-22.48bn-22.48bn62.27m------------------------------------------------------182.51------
Corline Biomedical AB6.61m-2.43m62.30m14.00--1.89--9.43-0.3005-0.30050.81654.070.1729--4.691,349,769.00-6.36-5.71-7.13-6.24141.25128.60-36.80-38.46---306.520.00--6.2874.14-177.67--62.51--
Lasa Supergenerics Ltd49.29m-9.19m63.93m77.00------1.30-3.92-3.9220.94--------13,586,300.00---3.86---5.3426.4132.53-18.65-5.30---4.49-----19.47-9.2643.73------
Marinomed Biotech AG28.42m-29.55m65.50m47.00------2.30-4.46-4.464.28-7.69------140,468.10---33.46---48.7310.567.67-103.99-69.701.46-4.512.20---18.5614.50-6.21---10.92--
Cosma SA3.95m-47.03m65.51m31.00--1.92--16.58-0.4301-0.43010.03620.23430.07330.84093.05136,278.60-87.24---91.46--58.45---1,189.90--0.5634-129.620.0119-------18,399.08------
Vaidya Sane Ayurved Laboratories Ltd46.80m933.06k66.38m636.0080.542.5327.451.421.661.6678.5452.891.586.8315.111,561,813.003.164.834.027.4974.1270.912.002.532.115.490.0293--0.16389.71-59.0231.914.43--
Can Fite Biopharma Ltd2.64m-29.14m66.78m5.00--5.57--25.33-0.0175-0.01750.00160.00550.0787----495,100.80-86.95-102.29-115.77-131.07-----1,105.10-1,105.36----0.00---8.27-27.9224.96---42.92--
Devonian Health Group Inc27.99m-9.10m68.07m6.00--1.78--2.43-0.0216-0.02160.06650.090.442333.072.321,625,238.00-14.37-21.02-23.15-23.9630.9529.96-32.50-131.971.06-9.410.1406--1.74-5.83-33.39------
Cumberland Pharmaceuticals, Inc.149.67m-41.10m69.79m91.00--0.6681--0.4663-0.7328-0.73282.671.870.45010.86433.17415,225.80-12.35-7.03-17.75-9.5282.5879.95-27.45-17.641.26-38.850.382---5.856.15-12.73---36.17--
Data as of Oct 18 2024. Currency figures normalised to Cosma SA's reporting currency: Polish New Zloty PLN
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.